Professor Daniel C. Baumgart, MD, PhD, MBA, FEBG, FACP, FRCP (London), AGAF completed his medical studies in Berlin, Basel, and Würzburg. He received clinical and research training training as a fellow of the German Academic Exchange Service (DAAD) and the German Research Foundation (DFG) at the University of Pennsylvania (Philadelphia, PA), Georgetown University (Washington, DC), the National Institutes of Health (NIH) in Bethesda, MD, USA, and at Charite.
He is a Professor of Medicine at Charité. Until 2017, he served as Deputy Chief of the Department of Gastroenterology and Hepatology at Virchow Hospital and was an elected Fellow at the Berlin Institute of Health (BIH), endowed by the StiftungCharité foundation. In 2023, he was appointed Chief of the Department of Gastroenterology, Hepatology, Infectious Diseases, and Rheumatology at Ernst von Bergmann Hospital.
Since 2017, he has also been a Professor of Medicine at the University of Alberta in Edmonton, Canada. There, until 2022, he directed the University Division of Gastroenterology and Hepatology, which under his leadership was ranked in U.S. News & World Report’s “Best Global Universities” as the University of Alberta’s top-rated unit and second best in Canada.
As an internationally renowned expert in inflammatory bowel diseases (IBD), Professor Baumgart is focused on developing innovative diagnostic and therapeutic strategies for Crohn's disease and ulcerative colitis, as exemplified in his publication in the New England Journal of Medicine. As Principal Investigator, he has overseen more than 150 Phase I–IV clinical trials and serves as Co–Principal Investigator within the Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects (IMAGINE SPOR) network.
A pioneer in the digital transformation of medicine, he is also an Adjunct Professor of Computing Science in the Faculty of Science (Department of Computing Science) at the University of Alberta and a founding member of the University of Alberta Precision Health and AI4Society Signature Areas. Among other accomplishments, he helped establish Alberta’s first digital big-data patient registry. For more than two decades, he has advanced digital innovation, artificial intelligence (AI), and clinical decision-support systems, with the goal of sustainably integrating personalized precision medicine and individually tailored therapies into routine clinical care.
Among other accomplishments, he helped establish Alberta’s first digital big-data patient registry. For more than two decades, he has advanced digital innovation, artificial intelligence (AI), and clinical decision-support systems, with the goal of sustainably integrating personalized precision medicine and individually tailored therapies into routine clinical care.
In an article for Nature Portfolio Digital Medicine, Prof. Baumgart examines the potential of Canada’s largest fully integrated digital health system in Alberta for crisis management, public protection, and accelerating digital innovation in healthcare and the life sciences. He also serves as Principal Investigator and Program Director of the international graduate program “From Data to Decision (FD2D) – Digital Transformation and Artificial Intelligence from Data Value Chain to Human Value.” This research and training initiative brings together scientists and developers from 22 leading academic institutions and technology companies across North America, Europe, and Asia to investigate digital transformation and AI applications across disciplines and sectors. The program is funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), Mathematics of Information Technology and Complex Systems (Mitacs), and the University of Alberta. The work is conducted in collaboration with the Alberta Machine Intelligence Institute and the Kule Institute for Advanced Study and is further supported by the Canadian Institute for Advanced Research (CIFAR), the Canadian Institutes of Health Research (CIHR), the Social Sciences and Humanities Research Council of Canada (SSHRC), the University Hospital Foundation, and Alberta Innovates.
In 2023, at the invitation of Germany’s Federal Ministry of Health, Prof. Baumgart contributed to the “Data for Health” conference in Berlin and the subsequent workshop at Harvard University in Boston, collaborating with senior decision-makers from academia, civil society, and government. As a keynote speaker—including for the Bertelsmann Foundation, the Digital Health Forum, professional associations such as the German Association for Social Security Policy (GVG) or the German Association of Health IT vendors (BVITG), and members of the German Parliament's (Bundestag’s) Committee on Health—his international perspective on the digital transformation of medicine and healthcare has been widely recognized.
Prof. Baumgart is Deputy Editor of Nature Portfolio Digital Medicine and serves on the editorial board of The Lancet and.Gut. He also chairs one of the AI in IBD Working Groups of the European Crohn’s and Colitis Organisation (ECCO)and serves on numerous national and international expert committees.
As an alumnus of the BMW Foundation Herbert Quandt, he is deeply committed to responsible leadership and supporting early-career scientists. His Clinician Scientist concept for integrated clinical and scientific training-recognized under the Off the Beaten Track program of the Volkswagen Foundation-has been acknowledged by the German Research Foundation (DFG), the German Federal Ministry of Education and Research (BMBF), and the German Council of Science and Humanities (WR) as thenational model program for academic medicine.
In recognition of his contributions, Professor Baumgart was named a Fellow of the American College of Physicians (FACP) in 2013, a Fellow of the American Gastroenterological Association (AGAF) in 2014, and a Fellow of the Royal College of Physicians (FRCP, London) in 2017.

AI4Society Funded Projects

• AI Ethics and Privacy (C-Eth3)